Datenübermittlung zwischen den Krankenkassen und dem Paul-Ehrlich-Institut zu Verdachtsfällen von COVID-19-Impfschäden

This procedure is a written question concerning the exchange of data between health insurance funds and the Paul Ehrlich Institute. It seeks to clarify how suspected cases of COVID-19 vaccine side effects are reported and tracked to ensure public health safety. This affects health insurance providers, the Paul Ehrlich Institute, and individuals who have reported suspected vaccine injuries.